Literature DB >> 19182304

Interatrial septal closure devices and aortic perforation: a note of caution.

Steffen P Schoen1, Stefan Wiedeman, Manja Bock, Utz Kappert, Ruth H Strasser.   

Abstract

Percutaneous defect closure is well established in patients with a symptomatic patent foramen ovale (PFO). Despite a safe interventional procedure, severe complications have been described during device implantation or follow up. Two patients are described whose cases may serve to warn of an unusual complication associated with a closure device. Several weeks after percutaneous PFO closure, perforation of a device strut into the aortic root was evident in both asymptomatic patients. The perforations were repaired surgically and both patients had further uneventful follow-ups. Procedures which could decrease the risk of device perforation should be adhered to and the indication for closure should consider this potential complication.

Entities:  

Mesh:

Year:  2009        PMID: 19182304

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  4 in total

1.  Long-term results of the amplatzer cribriform occluder for patent foramen ovale with associated atrial septal aneurysm: impact on occlusion rate and left atrial functional remodelling.

Authors:  Gianluca Rigatelli; Fabio Dell'avvocata; Paolo Cardaioli; Gabriele Braggion; Massimo Giordan; Alberto Mazza; Chiara Fraccaro; Mauro Chinaglia; Jack P Chen
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

Review 2.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

3.  Is the Sac Waiting to Rupture? Sinus of Valsalva Aneurysm.

Authors:  Ankur Phatarpekar; Milind Phadke; Charan Lanjewar; Prafulla Kerkar
Journal:  Aorta (Stamford)       Date:  2016-06-01

4.  Retrieval of Embolized Amplatzer Patent Foramen Ovale Occlusion Device: Issues Related to Late Recognition.

Authors:  Allan J Davies; Nicholas Collins; Nicole Organ
Journal:  Case Rep Cardiol       Date:  2017-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.